This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 4 - 8, 2022
Marriott Marquis San DiegoDelivered as a Hybrid Event

December 4 - 8, 2022
Marriott Marquis San Diego,
Delivered as a Hybrid Event

THE #1 ANTIBODY ENGINEERING CONFERENCE FOR ACCELERATING NEXT GENERATION ANTIBODIES TO COMMERCIAL SUCCESS

Call for Speakers and Early-Reg Now Open for 2022!

Celebrating 33 Years of Bringing The Community Together to Discuss Time-Critical Antibody Engineering Updates and Best Practices

Brand New Session Themes for 2022:

  • Antibody engineering, libraries and selection (including HTS)
  • Machine learning/artificial intelligence in antibody discovery and engineering
  • Fc-engineering & other (non IgG1/IgG4) subclasses
  • Antibody-drug conjugates, toxins and other conjugates
  • Cellular therapies: CART's (T and NK) (non-cell engaging)
  • Bispecifics / multispecifics / combinations (non-cell engaging)
  • Antibodies in Infectious diseases
  • T cell (including gamma/delta) and NK cell engagers

Brand New Session Themes for 2022:

  • Advancing antibody therapeutics in immuno-oncology
  • Tumor microenvironment (including immunocytokines)
  • Novel/difficult targets for antibody therapeutics (e.g. MHCp, GPRC, glycans etc)
  • How to develop an antibody-based drug: from discovery to IND?
  • Adaptive immune receptor repertoire data processing, annotation and interpretation
  • Antibodies in non-cancer (Autoimmune, neurological and other diseases)
  • Functional Screening Integrated Into Initial Antibody Discovery

3 Unmissable Add-On Options

Extend your learning even further with 3 vital add-on options designed to embed your knowledge prior to the main conference. 

Options include:

  • Pre-Conference Half-Day Workshop A (PM): How to Develop an Antibody-based Drug from Discovery to IND?
  • Pre-Conference Half-Day Workshop B (PM): Adaptive Immune Receptor Repertoire Data Processing, Annotation and Interpretation
  • Pre-Conference Full-Day Training Course: Introduction to Antibody Engineering


Michael Kierny, PhD

Scientist I

AstraZeneca

With fascinating presentations from high caliber speakers, the Antibody Engineering conference is essential to understanding the advances in the field.

Put Yourself Infront Of Key Antibody Decision-Makers!

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Blake Shuka
blake.shuka@informa.com | (+1) 212-600-3451

About the Antibody Society

The Antibody Society is an international, non-profit representing individuals and organizations involved in antibody-related research and development. The Society has a variety of initiatives and working groups focused on improving the antibody field. 

We are:

  • Creating opportunities for education and networking;
  • Monitoring and reporting advances in the commercial pipeline for antibody and CAR-T therapeutics;
  • Creating standards for characterizing antibody and T-cell receptor repertoires, and engaging this field;
  • Engaging government and international agencies on matters concerning the antibody community;

 Please join us!

Informa AllSecure is Informa’s approach to enhanced health and safety standards at our events following COVID-19

Informa AllSecure

Vaishali Kapoor

Instructor

Washington University in St. Louis School of Medicine

Great meeting! Good learning and networking experience.